* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for Dynasil of America's PEG Ratio or its related term are showing as below:
DYSL's PEG Ratio is not ranked *
in the Hardware industry.
Industry Median: 1.58 * Ranked among companies with meaningful PEG Ratio only.
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
Dynasil of America PEG Ratio Historical Data
The historical data trend for Dynasil of America's PEG Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Dynasil of America's PEG Ratio
For the Scientific & Technical Instruments subindustry, Dynasil of America's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dynasil of America's PEG Ratio Distribution in the Hardware Industry
For the Hardware industry and Technology sector, Dynasil of America's PEG Ratio distribution charts can be found below:
* The bar in red indicates where Dynasil of America's PEG Ratio falls into.
Dynasil of America PEG Ratio Calculation
PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio.
The ratio we use is the 5-Year EBITDA growth rate.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Dynasil of America (OTCPK:DYSL) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
Dynasil of America PEG Ratio Related Terms
Thank you for viewing the detailed overview of Dynasil of America's PEG Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Dynasil of America (Dynasil of America) Business Description
Dynasil Corp of America is a US-based company. It operates in three segments. The Optics segment, which is the key revenue driver, encompasses Dynasil Fused Silica, Evaporated Metal Films, Hilger Crystals, and Optometrics. It manufactures commercial products, including optical crystals for sensing in the security and medical imaging markets, and optical components, optical coatings and optical materials for scientific instrumentation and other applications. The Innovation and Development segment consists of the Radiation Monitoring Devices. The Biomedical segment consists of Dynasil Biomedical, a medical technology incubator that owns rights to certain early-stage medical technologies.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
DYSL has been successfully added to your 